Medigus Income Statement Research

MDGS Stock  USD 2.74  0.10  3.52%   
Most accounts from Medigus' income statement are interrelated and interconnected. However, analyzing income statement accounts one by one will only give a small insight into Medigus Ltd ADR current financial condition. On the other hand, looking into the entire matrix of income statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Medigus Valuation and Medigus Correlation analysis.
  
At this time, Medigus' Total Operating Expenses is comparatively stable compared to the past year. Income Tax Expense is likely to gain to about 134 K in 2024, whereas EBIT is likely to drop (13 M) in 2024.
Most accounts from Medigus' income statement are interrelated and interconnected. However, analyzing income statement accounts one by one will only give a small insight into Medigus Ltd ADR current financial condition. On the other hand, looking into the entire matrix of income statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Medigus Valuation and Medigus Correlation analysis.
At this time, Medigus' Total Operating Expenses is comparatively stable compared to the past year. Income Tax Expense is likely to gain to about 134 K in 2024, whereas EBIT is likely to drop (13 M) in 2024.
 2021 2022 2023 2024 (projected)
Total Operating Expenses13.0M23.0M26.5M27.8M
Cost Of Revenue5.3M77.4M89.0M93.5M

Medigus income statement Correlations

-0.010.150.260.140.25-0.12-0.140.460.670.280.11-0.67-0.79-0.67-0.17-0.75-0.11-0.19-0.20.27
-0.010.720.840.850.87-0.88-0.830.32-0.640.840.95-0.460.4-0.470.8-0.480.50.75-0.830.84
0.150.720.890.90.9-0.68-0.670.84-0.390.880.89-0.350.3-0.360.91-0.410.750.4-0.880.88
0.260.840.890.991.0-0.66-0.630.67-0.281.00.93-0.370.26-0.380.82-0.470.740.5-0.981.0
0.140.850.90.990.99-0.64-0.620.65-0.360.990.94-0.280.37-0.290.86-0.380.790.5-0.980.99
0.250.870.91.00.99-0.7-0.680.66-0.321.00.95-0.410.26-0.410.84-0.50.720.52-0.981.0
-0.12-0.88-0.68-0.66-0.64-0.70.97-0.420.64-0.66-0.860.71-0.180.72-0.710.65-0.26-0.660.66-0.66
-0.14-0.83-0.67-0.63-0.62-0.680.97-0.430.64-0.63-0.830.67-0.210.68-0.70.65-0.28-0.60.64-0.63
0.460.320.840.670.650.66-0.42-0.430.030.670.59-0.39-0.07-0.40.6-0.460.61-0.06-0.660.67
0.67-0.64-0.39-0.28-0.36-0.320.640.640.03-0.26-0.54-0.01-0.770.0-0.66-0.09-0.29-0.590.33-0.27
0.280.840.881.00.991.0-0.66-0.630.67-0.260.93-0.380.24-0.390.81-0.490.730.49-0.981.0
0.110.950.890.930.940.95-0.86-0.830.59-0.540.93-0.480.34-0.490.89-0.530.640.62-0.920.93
-0.67-0.46-0.35-0.37-0.28-0.410.710.67-0.39-0.01-0.38-0.480.561.0-0.190.960.1-0.330.33-0.38
-0.790.40.30.260.370.26-0.18-0.21-0.07-0.770.240.340.560.550.570.560.440.35-0.330.25
-0.67-0.47-0.36-0.38-0.29-0.410.720.68-0.40.0-0.39-0.491.00.55-0.20.960.09-0.340.34-0.39
-0.170.80.910.820.860.84-0.71-0.70.6-0.660.810.89-0.190.57-0.2-0.220.730.57-0.840.82
-0.75-0.48-0.41-0.47-0.38-0.50.650.65-0.46-0.09-0.49-0.530.960.560.96-0.22-0.06-0.270.41-0.48
-0.110.50.750.740.790.72-0.26-0.280.61-0.290.730.640.10.440.090.73-0.060.15-0.740.73
-0.190.750.40.50.50.52-0.66-0.6-0.06-0.590.490.62-0.330.35-0.340.57-0.270.15-0.530.5
-0.2-0.83-0.88-0.98-0.98-0.980.660.64-0.660.33-0.98-0.920.33-0.330.34-0.840.41-0.74-0.53-0.98
0.270.840.881.00.991.0-0.66-0.630.67-0.271.00.93-0.380.25-0.390.82-0.480.730.5-0.98
Click cells to compare fundamentals

Medigus Account Relationship Matchups

Medigus income statement Accounts

201920202021202220232024 (projected)
Total Revenue273K531K10.1M91.9M105.6M110.9M
Gross Profit(182K)(503K)4.8M14.5M16.6M17.5M
Operating Income(14.4M)(7.4M)(8.2M)(13.8M)(12.4M)(13.0M)
Ebit(14.4M)(7.4M)(8.2M)(13.8M)(12.4M)(13.0M)
Research Development609K997K1.0M4.9M4.4M4.6M
Ebitda(14.5M)(7.9M)(22.2M)(12.0M)(10.8M)(11.3M)
Cost Of Revenue455K1.0M5.3M77.4M89.0M93.5M
Income Before Tax(14.2M)(6.8M)4.2M(10.1M)(9.1M)(9.5M)
Net Income(14.2M)(6.9M)4.0M(10.2M)(9.2M)(9.6M)
Income Tax Expense(1K)9K105K111K127.7K134.0K
Interest Expense351K3.7M347K(4.1M)(3.7M)(3.5M)
Tax Provision(1K)9K105K111K127.7K134.0K
Net Interest Income99K205K(347K)(2.3M)(2.1M)(2.0M)

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Architect
When determining whether Medigus Ltd ADR is a strong investment it is important to analyze Medigus' competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Medigus' future performance. For an informed investment choice regarding Medigus Stock, refer to the following important reports:
Check out Medigus Valuation and Medigus Correlation analysis.
Note that the Medigus Ltd ADR information on this page should be used as a complementary analysis to other Medigus' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Content Syndication module to quickly integrate customizable finance content to your own investment portal.

Complementary Tools for Medigus Stock analysis

When running Medigus' price analysis, check to measure Medigus' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Medigus is operating at the current time. Most of Medigus' value examination focuses on studying past and present price action to predict the probability of Medigus' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Medigus' price. Additionally, you may evaluate how the addition of Medigus to your portfolios can decrease your overall portfolio volatility.
Idea Optimizer
Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio
Financial Widgets
Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets
Portfolio Center
All portfolio management and optimization tools to improve performance of your portfolios
Idea Breakdown
Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes
Sync Your Broker
Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.
Is Medigus' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Medigus. If investors know Medigus will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Medigus listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(8.70)
Revenue Per Share
67.313
Quarterly Revenue Growth
0.527
Return On Assets
(0.07)
Return On Equity
(0.31)
The market value of Medigus Ltd ADR is measured differently than its book value, which is the value of Medigus that is recorded on the company's balance sheet. Investors also form their own opinion of Medigus' value that differs from its market value or its book value, called intrinsic value, which is Medigus' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Medigus' market value can be influenced by many factors that don't directly affect Medigus' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Medigus' value and its price as these two are different measures arrived at by different means. Investors typically determine if Medigus is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Medigus' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.